EP0330380A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Novel indanoxyacetic acid derivatives and processes for preparing the same
Assignee: Tanabe Pharma Corp
•
Filing: 1989-02-17
•
Granted: —
•
Expires: 2009-02-17
Abstract
Abstract Novel indanoxyacetic acid derivatives of the formula: wherein R¹ is a lower alkyl group, a substituted or unsubstituted phenyl group, naphtyl group or a sulfur-containing heterocyclic group, R² is hydroxy group or a protected hydroxy group, p is an integer of 2 or 3, and q is an integer of 0 or 1, and a salt thereof are disclosed. Said derivative (I) and a salt thereof are useful as a platelet aggregation-inhibiting agent and an agent for the treatment, amelioration and/or prophylaxis of a variety of thrombosis, embolism, coronary and cerebral vascular smooth muscl vellication, asthma, and the like.
Inventors
- 👤 Takeo Iwakuma
- 👤 Harumichi Kohno
- 👤 Yasuhiko Sasaki
- 👤 Katsuo Ikezawa
- 👤 Akio Odawara
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-03 19:07
CPC Classifications
C; C07; C07C; C07C311/00; C07C311/01; C07C311/02; C07C311/07; A; A61; A61P; A61P7/00; A61P7/02; C07C311/15; C07C311/20; C07C2602/00; C07C2602/02; C07C2602/04; C07C2602/08
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
317 words
A process for preparing an indanoxyacetic acid derivative of the formula: wherein R¹ is a lower alkyl group, a substituted or unsubstituted phenyl group, naphthyl group of a sulfur-containing heterocyclic group, R² is a hydroxy group or a protected hydroxy group, p is an integer of 2 or 3 and q is an integer of 0 or 1, or a salt thereof, which comprises the step or steps of: A) condensing a compound of the formula: wherein Y is amino group or a reactive residue, and R², p and q are the same as defined above, or a salt thereof with a sulfonyl compound of the formula: R¹SO₂X¹ (III) wherein R¹ is the same as defined above, and a) X¹ is hydroxy group or a reactive residue when Y is amino group or b) X¹ is amino group when Y is a reactive residue; or B) condensing a compound of the formula: wherein R¹ is the same as defined above, or a salt thereof with a compound of the formula: X²CH₂CO-[NH-(CH₂) p -CO] q -R² (V) wherein X² is a reactive residue, and R², p and q are the same as defined above, to give the compound (I); or C) condensing a compound of the formula: wherein R¹ is the same as defined above, or a reactive derivative thereof with a compound of the formula: NH₂-(CH₂) p -COR² (VI) wherein p and R² are the same as defined above, to give a compound of the formula: wherein R¹, R² and p are the same as defined above; or D) removing a protecting group from a compound of the formula: wherein R²¹ is a protected hydroxy group, and R², p and q are the same as defined above, to give a compound of the formula: wherein R¹, R², and q are the same as defined above; and E) if required, further converting the product into a salt thereof.
Claim 2
Dependent Claim
317 words
A process for preparing an indanoxyacetic acid derivative of the formula: wherein R¹ is a lower alkyl group, a substituted or unsubstituted phenyl group, naphthyl group of a sulfur-containing heterocyclic group, R² is a hydroxy group or a protected hydroxy group, p is an integer of 2 or 3 and q is an integer of 0 or 1, or a salt thereof, which comprises the step or steps of: A) condensing a compound of the formula: wherein Y is amino group or a reactive residue, and R², p and q are the same as defined above, or a salt thereof with a sulfonyl compound of the formula: R¹SO₂X¹ (III) wherein R¹ is the same as defined above, and a) X¹ is hydroxy group or a reactive residue when Y is amino group or b) X¹ is amino group when Y is a reactive residue; or B) condensing a compound of the formula: wherein R¹ is the same as defined above, or a salt thereof with a compound of the formula: X²CH₂CO-[NH-(CH₂) p -CO] q -R² (V) wherein X² is a reactive residue, and R², p and q are the same as defined above, to give the compound (I); or C) condensing a compound of the formula: wherein R¹ is the same as defined above, or a reactive derivative thereof with a compound of the formula: NH₂-(CH₂) p -COR² (VI) wherein p and R² are the same as defined above, to give a compound of the formula: wherein R¹, R² and p are the same as defined above; or D) removing a protecting group from a compound of the formula: wherein R²¹ is a protected hydroxy group, and R², p and q are the same as defined above, to give a compound of the formula: wherein R¹, R², and q are the same as defined above; and E) if required, further converting the product into a salt thereof.
Claim 3
Dependent Claim
44 words
A process as claimed in Claim 1, wherein the reactants are such that R¹ is a C₁₋₄ alkyl group, phenyl group, a halogenophenyl group, a lower alkyl-phenyl group, naphthyl group or thienyl group, and R² is a hydroxy group or a C₁₋₄ alkoxy group.
Claim 4
Dependent Claim
39 words
A process as claimed in Claim 2, wherein the reactants are such that R¹ is a methyl group, phenyl group, chlorophenyl group, methylphenyl group, naphthyl group or thienyl group, and R² is a hydroxy group or a methoxy group.
Claim 5
Dependent Claim
20 words
A process as claimed in any one of the preceding claims wherein the reactants are such that q is 1.
Claim 6
Dependent Claim
20 words
A process as claimed in Claim 3, wherein the reactants are such that [2-(phenylsulfonylamino)indan -5-yl]oxyacetic acid or a salt thereof.
Claim 7
Dependent Claim
22 words
A process as claimed in Claim l, wherein the reactants are such that 3-{[2-(phenylsulfonylamino)indan -5-yl]oxyacetylamino}propionic acid or a salt thereof is produced.
Claim 8
Dependent Claim
20 words
A process as claimed in Claim 1, wherein the reactants are such that 3-{2-[(4-chlorophenyl) sulfonylamino]indan-5-yl]oxyacetylamino}propionic acid or a salt thereof.
Claim 9
Dependent Claim
37 words
A process as claimed in any one of the preceding claims wherein the resulting compound is purified and mixed with a pharmaceutically acceptable carrier to provide a pharmaceutical composition comprising a therapeutically effective amount of said compound.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.